Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Tommaso Schirinzi"'
Autor:
Cinzia Severini, Roberta Lattanzi, Antonio Greco, Daniela Maftei, Tommaso Schirinzi, Massimo Ralli, Nicola Biagio Mercuri
Publikováno v:
Movement disorders (2021). doi:10.1002/mds.28824
info:cnr-pdr/source/autori:Schirinzi T.; Maftei D.; Ralli M.; Greco A.; Mercuri N.B.; Lattanzi R.; Severini C./titolo:Serum Substance P Is Increased in Parkinson's Disease and Correlates with Motor Impairment/doi:10.1002%2Fmds.28824/rivista:Movement disorders/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Schirinzi T.; Maftei D.; Ralli M.; Greco A.; Mercuri N.B.; Lattanzi R.; Severini C./titolo:Serum Substance P Is Increased in Parkinson's Disease and Correlates with Motor Impairment/doi:10.1002%2Fmds.28824/rivista:Movement disorders/anno:2021/pagina_da:/pagina_a:/intervallo_pagine:/volume
Unavailable
Autor:
Piergiorgio La Rosa, Fiorella Piemonte, Riccardo Turchi, Daniele Lettieri-Barbato, Maria Teresa Fiorenza, Francesco Berardinelli, Katia Aquilano, Enrico Bertini, Sara Petrillo, Tommaso Schirinzi, Gessica Vasco
Publikováno v:
Redox Biology
Redox Biology, Vol 38, Iss, Pp 101791-(2021)
Redox Biology, Vol 38, Iss, Pp 101791-(2021)
Ferroptosis is an iron-dependent cell death caused by impaired glutathione metabolism, lipid peroxidation and mitochondrial failure. Emerging evidences report a role for ferroptosis in Friedreich's Ataxia (FRDA), a neurodegenerative disease caused by
Autor:
Enrico Castelli, Enrico Bertini, Maurizio Petrarca, Ginevra Zanni, Gessica Vasco, Silvia Minosse, Andrea Sancesario, Alberto Romano, Martina Favetta, Susanna Summa, Tommaso Schirinzi
Publikováno v:
Cerebellum & Ataxias, Vol 6, Iss 1, Pp 1-5 (2019)
Background The recessive ataxia ARCA2 is a rare disorder characterized by Coenzyme Q10 (CoQ10) deficiency due to biallelic mutations in ADCK3 gene. Despite the pathophysiological role, available data are not univocal on clinical efficacy of CoQ10 sup
Autor:
Fiorella Piemonte, Tommaso Schirinzi, Antonio Pisani, Vito Luigi Colona, Mariangela Pierantozzi, Luisa Mari, Jessica D’Amico, Giulia Di Lazzaro, Enrico Bertini, Nicola Biagio Mercuri, Sara Petrillo
Background Preclinical studies underlined the relevance of Nuclear factor erythroid 2-related factor 2 (Nrf2) transcription factor pathway in the pathogenesis of Parkinson's disease (PD). Objective The objective of this study was to explore Nrf2 path
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f57afed4da1e15b4d84f449b68eace00
Autor:
Alessandro Martorana, Tommaso Schirinzi, Paola Imbriani, Giulia Di Lazzaro, Antonio Pisani, Vito Luigi Colona, Giulia Maria Sancesario, Mohammad Alwardat
Publikováno v:
Journal of Neural Transmission. 124:1105-1108
Low levels of serum uric acid (UA) are a risk factor for many neurodegenerative diseases but the role of UA in tauopathies has not been yet fully evaluated. In this study, we assessed the risk associated with serum UA levels in a large group of patie
Autor:
Cristina Cariulo, Paola Martufi, Margherita Verani, Lucia Azzollini, Giordana Bruni, Andreas Weiss, Sean M. Deguire, Hilal A. Lashuel, Eugenia Scaricamazza, Giulia Maria Sancesario, Tommaso Schirinzi, Nicola Biagio Mercuri, Giuseppe Sancesario, Andrea Caricasole, Lara Petricca
Publikováno v:
Frontiers in Neuroscience
Frontiers in Neuroscience, Vol 13 (2019)
Frontiers in Neuroscience, Vol 13 (2019)
Accumulation and aggregation of misfolded alpha-synuclein is believed to be a cause of Parkinson's disease (PD). Phosphorylation of alpha-synuclein at S129 is known to be associated with the pathological misfolding process, but efforts to investigate
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
Autor:
Tommaso Schirinzi, Giuseppina Martella, Paola Imbriani, Giulia Di Lazzaro, Donatella Franco, Vito Luigi Colona, Mohammad Alwardat, Paola Sinibaldi Salimei, Nicola Biagio Mercuri, Mariangela Pierantozzi, Antonio Pisani
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Frontiers in Neurology
Frontiers in Neurology
Effective disease-modifying treatments are an urgent need for Parkinson's disease (PD). A putative successful strategy is to counteract oxidative stress, not only with synthetic compounds, but also with natural agents or dietary choices. Vitamin E, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a42092086ddd4cc3ea660b5c19a989e
http://hdl.handle.net/2108/212637
http://hdl.handle.net/2108/212637
Autor:
Gessica Vasco, Fiorella Piemonte, Sara Petrillo, Ginevra Zanni, Enrico Bertini, Enrico Castelli, Tommaso Schirinzi
Publikováno v:
Clinical biochemistry. 54
Serum uric acid (UA) is a circulating antioxidant whose levels are typically lower in patients with idiopathic neurodegenerative diseases than healthy controls, reflecting a higher oxidative stress. Here we provided the first assessment of serum UA i
Autor:
Anna Pastore, Sara Petrillo, Rosalba Carrozzo, Fiorella Piemonte, Gessica Vasco, Tommaso Schirinzi, Enrico Bertini, Emanuela Piermarini
Publikováno v:
International Journal of Molecular Sciences; Volume 18; Issue 10; Pages: 2173
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 18, Iss 10, p 2173 (2017)
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 18, Iss 10, p 2173 (2017)
Oxidative stress is actively involved in Friedreich’s Ataxia (FA), thus pharmacological targeting of the antioxidant machinery may have therapeutic value. Here, we analyzed the relevance of the antioxidant phase II response mediated by the transcri
Autor:
Graziella Madeo, Laura Bonanni, Francesca Puglisi, Valentina Vanni, Jie Shen, Antonio Pisani, Elisabetta Ferraro, Enza Maria Valente, Giuseppina Martella, Nicola Biagio Mercuri, Paola Bonsi, Marta Maltese, Georgia Mandolesi, Tommaso Schirinzi
Publikováno v:
Neurobiology of Disease, Vol 91, Iss, Pp 21-36 (2016)
Heterozygous mutations in the PINK1 gene are considered a susceptibility factor to develop early-onset Parkinson's disease (PD), as supported by dopamine hypometabolism in asymptomatic mutation carriers and subtle alterations of dopamine-dependent st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3b0c0c8f0216f55cb4eadcea7941c18
http://hdl.handle.net/11568/1020508
http://hdl.handle.net/11568/1020508